ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $132 | +34.7% | 6,361 | +54.2% | 0.00% | – |
Q2 2023 | $98 | +71.9% | 4,125 | +35.8% | 0.00% | – |
Q1 2023 | $57 | -99.9% | 3,037 | -17.7% | 0.00% | – |
Q3 2022 | $60,000 | -16.7% | 3,689 | +18.4% | 0.00% | – |
Q4 2021 | $72,000 | +67.4% | 3,115 | +19.4% | 0.00% | – |
Q3 2021 | $43,000 | -40.3% | 2,609 | +92.4% | 0.00% | – |
Q4 2020 | $72,000 | +30.9% | 1,356 | 0.0% | 0.00% | – |
Q3 2020 | $55,000 | -67.8% | 1,356 | -66.6% | 0.00% | – |
Q1 2020 | $171,000 | -93.5% | 4,060 | -93.4% | 0.00% | -100.0% |
Q4 2019 | $2,645,000 | +9020.7% | 61,846 | +7488.5% | 0.00% | – |
Q3 2019 | $29,000 | – | 815 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |